-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Lexaria Bioscience Corp. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q3 2016 to Q3 2025.
- Lexaria Bioscience Corp. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending August 31, 2025 was $0.000.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)